DNase I Protein, Human (HEK293, His)
Based on 5 publication(s) in Google Scholar
The DNase I protein is a serum endonuclease secreted by a variety of exocrine and endocrine organs and expressed in non-hematopoietic tissues. It preferentially selects protein-free DNA, plays a key role in apoptosis-induced cell death, and inhibits actin polymerization by specifically binding to G-actin. DNase I Protein, Human (HEK293, His) is the recombinant human-derived DNase I protein, expressed by HEK293 , with C-His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
The DNase I protein is a serum endonuclease secreted by a variety of exocrine and endocrine organs and expressed in non-hematopoietic tissues. It preferentially selects protein-free DNA, plays a key role in apoptosis-induced cell death, and inhibits actin polymerization by specifically binding to G-actin. DNase I Protein, Human (HEK293, His) is the recombinant human-derived DNase I protein, expressed by HEK293 , with C-His labeled tag.
Background
DNase I, a serum endonuclease, is secreted by a diverse array of exocrine and endocrine organs. It is expressed in non-hematopoietic tissues and exhibits a preference for cleaving protein-free DNA. Apart from its general role as an endonuclease, DNase I plays a crucial role in apoptosis-induced cell death. Additionally, it binds specifically to G-actin, hindering actin polymerization. In collaboration with DNASE1L3, DNase I is instrumental in the degradation of neutrophil extracellular traps (NETs), which primarily consist of DNA fibers and are released by neutrophils during inflammation. The degradation of intravascular NETs by DNase I and DNASE1L3 is essential to prevent the formation of clots that could obstruct blood vessels, thereby mitigating organ damage following inflammatory responses.
Verified Bioactivity
One unit is defined as the amount of DNase I that degrades DNA and causes an increase in absorbance at 260 nm of 0.001/minute and the specific activity is >5000 unit/mg.
MCE Validation Data
-
Purity - SDS-PAGE
Purity - SDS-PAGE
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
FGF19-Induced Inflammatory CAF Promoted Neutrophil Extracellular Trap Formation in the Liver Metastasis of Colorectal Cancer. [Abstract]2023 Aug;10(24):e2302613. PMID: 37345586 -
Cell Death Discov
Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles. [Abstract]2024 Sep 5;10(1):395. PMID: 39237520 -
Cell Biosci
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. [Abstract]2023 Aug 10;13(1):147. PMID: 37563620 -
J Inflamm Res
DNase I and Sivelestat Ameliorate Experimental Hindlimb Ischemia-Reperfusion Injury by Eliminating Neutrophil Extracellular Traps. [Abstract]2023 Feb 21:16:707-721. PMID: 36852300 -
J Orthop Surg Res
TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling. [Abstract]2023 Mar 5;18(1):168. PMID: 36872331
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-6*His
-
Accession
P24855-1 (L23-K282)
-
Molecular Construction
-
N-term
-
DNASE1 (L23-K282)
Accession # P24855-1 -
6*His
-
C-term
-
-
Protein Length
Full Length of Isoform-1
-
Synonyms
DNASE1; DRNI; Prev. DNL1; Alternative Protein DNASE1; Deoxyribonuclease I; DNase I, Lysosomal; Deoxyribonuclease-1; DNase I; Dornase Alfa; DNAse1; Deoxyribonuclease 1; Human Urine Deoxyribonuclease I
-
AA Sequence
LKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRPSQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDRIVVAGMLLRGAVVPDSALPFNFQAAYGLSDQLAQAISDHYPVEVMLK
-
Predicted Molecular Mass
30.1 kDa
-
Molecular Weight
Approximately 37 kDa, based on SDS-PAGE under reducing conditions.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder
Lyophilized from a 0.22 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (237 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)